glp-1 news nov 2025 November in review: breakthroughs, UPFs under fire, Novonesis advances healthy longevity glp-1 news 2025 november Agonists

Glucagon-Like Peptide 1 Receptor Agonist Use and Risk of Thyroid Cancer: Scandinavian Cohort Study

Welcome to Metabolic Mind, a non-profit initiative of Baszucki Group, transforming the study and treatment of mental disorders by exploring the connection between metabolism and brain health

A head-to-head review of clinical studies determined that among available GLP-1 RAs, there were A1C reductions from 0.78% to 1.9%

Some patients experience nausea, constipation, or vomiting

In many ways, your microbiome acts like a metabolic control panel influencing hunger, satiety, and energy regulation

Treatment discontinuation (46%) was the most common reason for censoring (Supplementary Table 20)